{"name": "Lux Biosciences",
 "permalink": "lux-biosciences",
 "crunchbase_url": "http://www.crunchbase.com/company/lux-biosciences",
 "homepage_url": "http://www.luxbio.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2005,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "bd@luxbio.com",
 "phone_number": "201-946-0551",
 "description": "",
 "created_at": "Tue Oct 20 01:47:58 UTC 2009",
 "updated_at": "Tue Oct 20 01:47:58 UTC 2009",
 "overview": "\u003Cp\u003ELux Biosciences, Inc., a biotechnology company, develops medications to treat ophthalmic diseases. Its products include LX201, a silicone matrix ocular implant that enables the release of cyclosporine A to the eye for one year; Luveniq, an oral form of calcineurin inhibitor voclosporin; LX212, a bioerodible polymer implant that contains voclosporin; and LX214, a topical mixed nanomicellar formulation of voclosporin therapy for dry eyes. The company was founded in 2005 and is based in Jersey City, New Jersey.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[123,
       82],
      "assets/images/resized/0006/3157/63157v1-max-150x150.jpg"],
     [[123,
       82],
      "assets/images/resized/0006/3157/63157v1-max-250x250.jpg"],
     [[123,
       82],
      "assets/images/resized/0006/3157/63157v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Co-Founder and Chief Medical Officer ",
    "person":
     {"first_name": "Eddy",
      "last_name": "Anglade",
      "permalink": "eddy-anglade",
      "image": null}},
   {"is_past": false,
    "title": " Co-Founder",
    "person":
     {"first_name": "Ulrich",
      "last_name": "Grau",
      "permalink": "ulrich-grau",
      "image": null}},
   {"is_past": false,
    "title": "CEO ",
    "person":
     {"first_name": "Dean",
      "last_name": "J. Mitchell",
      "permalink": "dean-j-mitchell",
      "image": null}},
   {"is_past": false,
    "title": " Co-Founder and Vice President of Program Management ",
    "person":
     {"first_name": "Sidney",
      "last_name": "L. Weiss",
      "permalink": "sidney-l-weiss",
      "image": null}},
   {"is_past": true,
    "title": "Director",
    "person":
     {"first_name": "David",
      "last_name": "Schnell",
      "permalink": "david-schnell",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$50M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://venturebeat.com/2009/10/19/lux-biosciences-scores-50m-series-b-for-eye-cure/",
    "source_description": "Lux Biosciences scores $50M Series B for eye cure",
    "raised_amount": 50000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 10,
    "funded_day": null,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "HBM BioVentures",
         "permalink": "hbm-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0482/50482v1-max-150x150.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-250x250.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novo A/S",
         "permalink": "novo-a-s",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0025/1103/251103v1-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-250x250.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Prospect Venture Partners",
         "permalink": "prospect-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               81],
              "assets/images/resized/0003/4207/34207v1-max-150x150.png"],
             [[195,
               106],
              "assets/images/resized/0003/4207/34207v1-max-250x250.png"],
             [[195,
               106],
              "assets/images/resized/0003/4207/34207v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Harborside Financial Center Plaza 10",
    "address2": "14th Floor 3 Second Street",
    "zip_code": "07302",
    "city": "Jersey City",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}